Short answer · Medically reviewed summary · Last updated: 2026-05-08
Progressive Osseous Heteroplasia (POH) is a rare genetic condition caused by inactivating mutations in the GNAS gene, which leads to abnormal bone formation in soft tissues like skin, muscle, and fat. Because this condition is driven by specific genetic alterations, it is not caused by environmental triggers, infections, or lifestyle factors. What causes Progressive Osseous Heteroplasia? The primary cause of Progressive Osseous Heteroplasia is a mutation in the GNAS gene located on chromosome 20q13.32.
Progressive Osseous Heteroplasia (POH) is a rare genetic condition caused by inactivating mutations in the GNAS gene, which leads to abnormal bone formation in soft tissues like skin, muscle, and fat. Because this condition is driven by specific genetic alterations, it is not caused by environmental triggers, infections, or lifestyle factors.
The primary cause of Progressive Osseous Heteroplasia is a mutation in the GNAS gene located on chromosome 20q13.32. This gene is responsible for producing a protein called Gs-alpha, which acts as a molecular "on-off" switch for various hormonal signals in the body. In Progressive Osseous Heteroplasia, the mutation specifically affects the paternal allele, causing cells that should develop into soft tissue to mistakenly "switch" into bone-forming cells, a process known as heterotopic ossification.
While Progressive Osseous Heteroplasia is a genetic disorder, it is most often the result of a "de novo" or spontaneous mutation, meaning it occurs for the first time in an individual. However, because it follows an autosomal dominant inheritance pattern, a person with Progressive Osseous Heteroplasia has a 50% chance of passing the GNAS mutation to their offspring. Genetic counseling is essential for families navigating this diagnosis.
The clinical manifestation of Progressive Osseous Heteroplasia involves the transformation of mesenchymal stem cells into osteoblasts (bone cells). Key characteristics of this process include:
Current research into Progressive Osseous Heteroplasia focuses on understanding how the loss of Gs-alpha signaling triggers this abnormal cell differentiation. Scientists are investigating therapeutic pathways that might inhibit these bone-forming signals. While the underlying genetic cause is well-identified, the exact molecular "triggers" that cause one area of tissue to ossify while another remains unaffected are still being studied.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.